Topic: contract research organizations
XenoGesis and BioAscent plan to integrate their drug discovery offerings.
PolarityTE, offering scant details, acquired an unnamed CRO to expand its R&D programs and appointed a new veterinary officer.
Charles River Laboratories and The Michael J. Fox Foundation for Parkinson’s Research have extended their collaboration.
Charles River Labs is expanding its services into the early discovery setting, offering high-speed pharmacokinetics screening of compounds’ underlying biology.
RxCelerate has absorbed the services and staff of Total Scientific, a CRO focused in bioanalysis, protein assays and gene-phenotype association.
WuXi AppTec’s contract development and manufacturing subsidiary plans to build a new R&D center in Shanghai, next door to its production plant.
A hospital in India is accused of misleading people into joining a clinical trial of a Glenmark Pharmaceuticals painkiller without their consent.
The U.K. will endeavor to keep pace with the European Union’s impending changes in clinical trial procedures post-Brexit.
The platform uses wearables to continuously collect clinical data from study participants and applies machine learning to analyze the data.
WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.